SCHEMBL144502

SCHEMBL144502

CCC(NC(=O)CCCCCCCCCCCCCCC(C)C)N1CCOCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
FAAH O00519 2/20 0.41
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPK1 P28482 2/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
NFKB1 P19838 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
MAPT P10636 1/20 0.40
UGCG Q16739 1/20 0.40
MTOR P42345 1/20 0.40
GMNN O75496 1/20 0.39
BLM P54132 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lactic Acid SCHEMBL344500 0.94 FAAH (0.45) ALDH1A1LMNAHTTSMN1; SMN2FAAH
SCHEMBL8435127 0.87 ALDH1A1 (0.54) ALDH1A1LMNAHTTSMN1; SMN2FAAH
SCHEMBL1514267 0.87 ALDH1A1 (0.54) ALDH1A1LMNAHTTSMN1; SMN2FAAH
SCHEMBL8435136 0.87 ALDH1A1 (0.54) ALDH1A1LMNAHTTSMN1; SMN2FAAH
SCHEMBL2769843 0.86 LMNA (0.42) ALDH1A1LMNAHTTSMN1; SMN2FAAH
Lactic Acid SCHEMBL427894 0.83 FAAH (0.50) ALDH1A1LMNAHTTSMN1; SMN2FAAH
SCHEMBL2119441 0.78 PLA2G10 (0.35) ALDH1A1LMNAHTTSMN1; SMN2FAAH
SCHEMBL5673619 0.78 FAAH (0.64) ALDH1A1LMNAHTTFAAHTP53
SCHEMBL10723388 0.76 FAAH (0.58) ALDH1A1LMNAHTTFAAHMEN1
SCHEMBL8670292 0.76 TSHR (0.40) ALDH1A1LMNAHTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797599-B9 METHOD AND IMPROVED PHARMACEUTICAL COMPOSITION FOR ENHANCING TRANSDERMAL DELIVERY OF PDE-5 INHIBITOR TRITECH BIOPHARMACEUTICALS CO LTD (TW) 2019-01-23 EP claimed
EP-2797599-B1 METHOD AND IMPROVED PHARMACEUTICAL COMPOSITION FOR ENHANCING TRANSDERMAL DELIVERY OF PDE-5 INHIBITOR TRITECH BIOPHARMACEUTICALS CO LTD (TW) 2018-09-12 EP claimed
US-20080113892-A1 Antimicrobial wash formulations including amidoamine-based cationic surfactants SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT 2008-05-15 US claimed
US-6620409-B2 A combination of dialkyl carbonate of the formula R1OC(O) OR2, wherein R1 and R2 independently of one another are a linear or branched c6-c12 alkyl group and an aminoalkyl amide of formula R3CONH(CH2)n-NR4R5; hair and skin care formulation HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-09-16 US claimed
WO-2022111829-A1 ESSENTIAL OILS OF CITRUS FRUITS FOR USE AS MEDICAMENT FOR INDUCED, INCREASED AND/OR ACCELERATED AUTOPHAGY IN HUMAN KERATINOCYTES SYMRISE AG (DE) 2022-06-02 WO disclosed
US-20200078273-A1 METHOD AND APPARATUS FOR REMOVAL OF CONTAMINANTS FROM SURFACES MCKINNON DANE MICHAEL J (US) 2020-03-12 US disclosed
US-10294764-B2 Methods and compositions for use in oil and/or gas wells FLOTEK CHEMISTRY, LLC (US) 2019-05-21 US disclosed
US-20180037792-A1 METHODS AND COMPOSITIONS FOR USE IN OIL AND/OR GAS WELLS FLOTEK CHEMISTRY, LLC (US) 2018-02-08 US disclosed
EP-3201302-A1 BIOSURFACTANT-CONTAINING FORMULATION Evonik Degussa GmbH (DE) 2017-08-09 EP disclosed
US-20160362634-A1 All-In-One Air Cleaner/Odor Eliminator, Surface Disinfectant and Surface Multipurpose/All Purpose Cleaner Y-CLEAN ENTERPRISES 2016-12-15 US disclosed
WO-2016197148-A1 ALL-IN-ONE AIR CLEANER/ODOR ELIMINATOR, SURFACE DISINFECTANT AND SURFACE MULTIPURPOSE/ALL PURPOSE CLEANER KIELBANIA ANDREW J JR (US) 2016-12-08 WO disclosed
WO-2016050439-A1 BIOSURFACTANT-CONTAINING FORMULATION EVONIK DEGUSSA GMBH (DE) 2016-04-07 WO disclosed
WO-2002007707-A2 LINKAGE OF AGENTS USING MICROPARTICLES PERICOR SCIENCE, INC. (US) 2002-01-31 WO disclosed
WO-2001007009-A1 LYSINE OXIDASE LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed
WO-2001006829-A2 LINKAGE OF AGENTS TO TISSUE PERICOR SCIENCE, INC. (US) 2001-02-01 WO disclosed
EP-1011609-A4 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORP (US) 2000-08-16 EP disclosed
EP-1011609-A1 COMPOSITIONS FOR COSMETIC APPLICATIONS MedLogic Global Corporation (US) 2000-06-28 EP disclosed
WO-1998050005-A1 COMPOSITIONS FOR COSMETIC APPLICATIONS MEDLOGIC GLOBAL CORPORATION (US) 1998-11-12 WO disclosed
US-5556616-A Stable conditioning shampoo having a high foam level containing a graft copolymers of polyethyleneimine and silicone as a conditioner HELENE CURTIS, INC. (US) 1996-09-17 US disclosed
US-5417965-A Stable conditioning shampoo having a high foam level containing a silicone conditioner, a cationic quaternary acrylate copolymer, an anionic surfactant and polyethyleneimine HELENE CURTIS, INC. (US) 1995-05-23 US disclosed